Choose Your News
Loading...
Drugmaker Hikma Pharmaceuticals Plc said its full-year core operating profit rose 2.4 percent as weakness in its generic drugs business was more than offset... [Read More]
Drugmaker Hikma Pharmaceuticals Plc said its full-year core operating profit rose 2.4 percent as weakness in its generic drugs business was more than offset... [Read More]
Preview